search

Active clinical trials for "Neoplasms"

Results 3391-3400 of 64586

Surgical Pembro +/- Olaparib w TMZ for rGBM

GlioblastomaRecurrent Glioblastoma

This research study is studying a combination therapy as a possible treatment for recurrent glioblastoma (GBM), a brain tumor that is growing or progressing despite earlier treatment. The names of the study interventions involved in this study are/is: Pembrolizumab Olaparib Temozolomide (Temodar)

Recruiting105 enrollment criteria

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors

Colorectal Cancer

The purpose of this first-in-human study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary clinical activity of M9140 in advanced solid tumors. Study details include: Study Duration per participant: Approximately 4 months M9140 is not available through an expanded access program

Recruiting11 enrollment criteria

Study of BGB-11417 Monotherapy in Participants With Relapsed or Refractory Mantle Cell Lymphoma...

Mantle Cell LymphomaRefractory Mantle Cell Lymphoma (MCL)1 more

The study consists of two parts. Part 1 determines the safety and tolerability of BGB-11417 monotherapy, the maximum tolerated dose, and the recommended Phase 2 dose of BGB-11417 monotherapy for relapsed or refractory mantle cell lymphoma. Part 2 evaluates efficacy of BGB-11417 monotherapy at the recommended Phase 2 dose with recommended ramp-up schedule from Part 1.

Recruiting17 enrollment criteria

Study of Efficacy of BZ019 in Large B-cell Lymphoma

Large B-cell Lymphoma

This is a single arm,open-label, non-randomized phase 2 study to determine the efficacy of BZ019 in relapsed or refractory CD19+ B-cell Lymphoma subjects.

Recruiting39 enrollment criteria

Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab

Resectable Non-Small Cell Lung Cancer

This is an open label phase 2 clinical trial evaluating the clinical safety, feasibility and efficacy of neoadjuvant Adagrasib alone or in combination with nivolumab in patients with NSCLC with KRAS G12C mutation.

Recruiting53 enrollment criteria

Dietary Supplement on the Intestinal Microbiota in Patients With Colon Cancer

Colon Cancer

Effect of a dietary supplement with antioxidant and anti-inflamatory properties on the intestinal microbiota in patients with colon cancer. Ramdonized placebo controlled clinical trial. Teratrophic study

Recruiting17 enrollment criteria

Loncastuximab Tesirine for the Treatment of Relapsed or Refractory B-Cell Malignancies

Post-Transplant Lymphoproliferative DisorderRecurrent B-Cell Non-Hodgkin Lymphoma9 more

This phase II trial tests whether loncastuximab tesirine works to shrink tumors in patients with B-cell malignancies that have come back (relapsed) or does not respond to treatment (refractory). Loncastuximab tesirine is a monoclonal antibody, called loncastuximab, linked to a chemotherapy drug, called tesirine. Loncastuximab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as CD19 receptors, and delivers tesirine to kill them.

Recruiting30 enrollment criteria

Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor

Pediatric Germ Cell Tumor

Germ cell tumor has generally good prognosis, but high risk germ cell tumor has still very poor prognosis. There remains the need of further improvement with other chemotherapy strategy. Especially more than 11 years old, mediastinal germ cell tumor, stage 3 or 4 extragonodal germ cell tumor or the remained tumor after the primary treatment are the group with the poorest prognosis. Paclitaxel is widely used chemotherapeutic agent in adults and the experience of the agent has also been accumulated in children. The paclitaxel, ifosfamide, cisplatin (TIP) regimen has been used 2nd-line treatment for germ cell tumor and there is some promising result of the role of TIP in first line germ cell tumor treatment. In high risk pediatric germ cell tumor patients, TIP regimen will be able to reduce lung toxicity from the bleomycin as the standard regimen and to improve the survival. In this trial, the efficacy and safety of TIP as the first line treatment for germ cell tumor will be elucidated.

Recruiting41 enrollment criteria

Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or...

Acute Myeloid LeukemiaMyelodysplastic Syndromes

The purpose of this study is to evaluate the safety and preliminary activity of ARC-T cells and SPRX002 in participants with relapsed or refractory acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS)

Recruiting47 enrollment criteria

Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological Malignancies...

Tumor RecurrenceMalignant Epithelial Neoplasm of Vulva2 more

The study aims to obtain a local control rate in patients with lateral pelvic relapses of gynecologycal cancers previously irradiated. High LET (Linear Energy Transfer) particles as carbon ions can guarantee a biologic advantage compared to photons in radioresistant neoplasms, given to their higher biological efficacy (RBE).

Recruiting22 enrollment criteria
1...339340341...6459

Need Help? Contact our team!


We'll reach out to this number within 24 hrs